Global Meningococcal Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Meningococcal Vaccine market size was valued at US$ 256.3 million in 2023. With growing demand in downstream market, the Meningococcal Vaccine is forecast to a readjusted size of US$ 350.3 million by 2030 with a CAGR of 4.6% during review period.
The research report highlights the growth potential of the global Meningococcal Vaccine market. Meningococcal Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Meningococcal Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Meningococcal Vaccine market.
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%.
Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent.
In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.
Key Features:
The report on Meningococcal Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Meningococcal Vaccine market. It may include historical data, market segmentation by Type (e.g., Meningtits A, Polysaccharide Meningtitis AC), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Meningococcal Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Meningococcal Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Meningococcal Vaccine industry. This include advancements in Meningococcal Vaccine technology, Meningococcal Vaccine new entrants, Meningococcal Vaccine new investment, and other innovations that are shaping the future of Meningococcal Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Meningococcal Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Meningococcal Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Meningococcal Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Meningococcal Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Meningococcal Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Meningococcal Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Meningococcal Vaccine market.
Market Segmentation:
Meningococcal Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Meningococcal Vaccine market?
What factors are driving Meningococcal Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Meningococcal Vaccine market opportunities vary by end market size?
How does Meningococcal Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Meningococcal Vaccine market size was valued at US$ 256.3 million in 2023. With growing demand in downstream market, the Meningococcal Vaccine is forecast to a readjusted size of US$ 350.3 million by 2030 with a CAGR of 4.6% during review period.
The research report highlights the growth potential of the global Meningococcal Vaccine market. Meningococcal Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Meningococcal Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Meningococcal Vaccine market.
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%.
Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent.
In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.
Key Features:
The report on Meningococcal Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Meningococcal Vaccine market. It may include historical data, market segmentation by Type (e.g., Meningtits A, Polysaccharide Meningtitis AC), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Meningococcal Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Meningococcal Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Meningococcal Vaccine industry. This include advancements in Meningococcal Vaccine technology, Meningococcal Vaccine new entrants, Meningococcal Vaccine new investment, and other innovations that are shaping the future of Meningococcal Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Meningococcal Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Meningococcal Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Meningococcal Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Meningococcal Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Meningococcal Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Meningococcal Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Meningococcal Vaccine market.
Market Segmentation:
Meningococcal Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Meningtits A
- Polysaccharide Meningtitis AC
- Meningitis ACYW
- 6 Months-15Year
- over 3 Year
- over 2 Year
- over 3 Months
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- GSK
- Merck
- CSL
- Baxter
- JN International Medical Corporation
- Serum Institute of India
- Bio-Med
- China National Biotec Group
- Hualan Bio
- Walvax
- Zhifei
What is the 10-year outlook for the global Meningococcal Vaccine market?
What factors are driving Meningococcal Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Meningococcal Vaccine market opportunities vary by end market size?
How does Meningococcal Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Meningococcal Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Meningococcal Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Meningococcal Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Meningococcal Vaccine Segment by Type
2.2.1 Meningtits A
2.2.2 Polysaccharide Meningtitis AC
2.2.3 Meningitis ACYW
2.3 Meningococcal Vaccine Sales by Type
2.3.1 Global Meningococcal Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Meningococcal Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Meningococcal Vaccine Sale Price by Type (2019-2024)
2.4 Meningococcal Vaccine Segment by Application
2.4.1 6 Months-15Year
2.4.2 over 3 Year
2.4.3 over 2 Year
2.4.4 over 3 Months
2.5 Meningococcal Vaccine Sales by Application
2.5.1 Global Meningococcal Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Meningococcal Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Meningococcal Vaccine Sale Price by Application (2019-2024)
3 GLOBAL MENINGOCOCCAL VACCINE BY COMPANY
3.1 Global Meningococcal Vaccine Breakdown Data by Company
3.1.1 Global Meningococcal Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Meningococcal Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Meningococcal Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Meningococcal Vaccine Revenue by Company (2019-2024)
3.2.2 Global Meningococcal Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Meningococcal Vaccine Sale Price by Company
3.4 Key Manufacturers Meningococcal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meningococcal Vaccine Product Location Distribution
3.4.2 Players Meningococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MENINGOCOCCAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Meningococcal Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Meningococcal Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Meningococcal Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Meningococcal Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Meningococcal Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Meningococcal Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Meningococcal Vaccine Sales Growth
4.4 APAC Meningococcal Vaccine Sales Growth
4.5 Europe Meningococcal Vaccine Sales Growth
4.6 Middle East & Africa Meningococcal Vaccine Sales Growth
5 AMERICAS
5.1 Americas Meningococcal Vaccine Sales by Country
5.1.1 Americas Meningococcal Vaccine Sales by Country (2019-2024)
5.1.2 Americas Meningococcal Vaccine Revenue by Country (2019-2024)
5.2 Americas Meningococcal Vaccine Sales by Type
5.3 Americas Meningococcal Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meningococcal Vaccine Sales by Region
6.1.1 APAC Meningococcal Vaccine Sales by Region (2019-2024)
6.1.2 APAC Meningococcal Vaccine Revenue by Region (2019-2024)
6.2 APAC Meningococcal Vaccine Sales by Type
6.3 APAC Meningococcal Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Meningococcal Vaccine by Country
7.1.1 Europe Meningococcal Vaccine Sales by Country (2019-2024)
7.1.2 Europe Meningococcal Vaccine Revenue by Country (2019-2024)
7.2 Europe Meningococcal Vaccine Sales by Type
7.3 Europe Meningococcal Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Meningococcal Vaccine by Country
8.1.1 Middle East & Africa Meningococcal Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Meningococcal Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Meningococcal Vaccine Sales by Type
8.3 Middle East & Africa Meningococcal Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meningococcal Vaccine
10.3 Manufacturing Process Analysis of Meningococcal Vaccine
10.4 Industry Chain Structure of Meningococcal Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meningococcal Vaccine Distributors
11.3 Meningococcal Vaccine Customer
12 WORLD FORECAST REVIEW FOR MENINGOCOCCAL VACCINE BY GEOGRAPHIC REGION
12.1 Global Meningococcal Vaccine Market Size Forecast by Region
12.1.1 Global Meningococcal Vaccine Forecast by Region (2025-2030)
12.1.2 Global Meningococcal Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Meningococcal Vaccine Forecast by Type
12.7 Global Meningococcal Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Meningococcal Vaccine Product Portfolios and Specifications
13.1.3 Novartis Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Meningococcal Vaccine Product Portfolios and Specifications
13.2.3 GSK Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Meningococcal Vaccine Product Portfolios and Specifications
13.3.3 Merck Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 CSL
13.4.1 CSL Company Information
13.4.2 CSL Meningococcal Vaccine Product Portfolios and Specifications
13.4.3 CSL Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CSL Main Business Overview
13.4.5 CSL Latest Developments
13.5 Baxter
13.5.1 Baxter Company Information
13.5.2 Baxter Meningococcal Vaccine Product Portfolios and Specifications
13.5.3 Baxter Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Baxter Main Business Overview
13.5.5 Baxter Latest Developments
13.6 JN International Medical Corporation
13.6.1 JN International Medical Corporation Company Information
13.6.2 JN International Medical Corporation Meningococcal Vaccine Product Portfolios and Specifications
13.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 JN International Medical Corporation Main Business Overview
13.6.5 JN International Medical Corporation Latest Developments
13.7 Serum Institute of India
13.7.1 Serum Institute of India Company Information
13.7.2 Serum Institute of India Meningococcal Vaccine Product Portfolios and Specifications
13.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Serum Institute of India Main Business Overview
13.7.5 Serum Institute of India Latest Developments
13.8 Bio-Med
13.8.1 Bio-Med Company Information
13.8.2 Bio-Med Meningococcal Vaccine Product Portfolios and Specifications
13.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Bio-Med Main Business Overview
13.8.5 Bio-Med Latest Developments
13.9 China National Biotec Group
13.9.1 China National Biotec Group Company Information
13.9.2 China National Biotec Group Meningococcal Vaccine Product Portfolios and Specifications
13.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 China National Biotec Group Main Business Overview
13.9.5 China National Biotec Group Latest Developments
13.10 Hualan Bio
13.10.1 Hualan Bio Company Information
13.10.2 Hualan Bio Meningococcal Vaccine Product Portfolios and Specifications
13.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Hualan Bio Main Business Overview
13.10.5 Hualan Bio Latest Developments
13.11 Walvax
13.11.1 Walvax Company Information
13.11.2 Walvax Meningococcal Vaccine Product Portfolios and Specifications
13.11.3 Walvax Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Walvax Main Business Overview
13.11.5 Walvax Latest Developments
13.12 Zhifei
13.12.1 Zhifei Company Information
13.12.2 Zhifei Meningococcal Vaccine Product Portfolios and Specifications
13.12.3 Zhifei Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Zhifei Main Business Overview
13.12.5 Zhifei Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Meningococcal Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Meningococcal Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Meningococcal Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Meningococcal Vaccine Segment by Type
2.2.1 Meningtits A
2.2.2 Polysaccharide Meningtitis AC
2.2.3 Meningitis ACYW
2.3 Meningococcal Vaccine Sales by Type
2.3.1 Global Meningococcal Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Meningococcal Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Meningococcal Vaccine Sale Price by Type (2019-2024)
2.4 Meningococcal Vaccine Segment by Application
2.4.1 6 Months-15Year
2.4.2 over 3 Year
2.4.3 over 2 Year
2.4.4 over 3 Months
2.5 Meningococcal Vaccine Sales by Application
2.5.1 Global Meningococcal Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Meningococcal Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Meningococcal Vaccine Sale Price by Application (2019-2024)
3 GLOBAL MENINGOCOCCAL VACCINE BY COMPANY
3.1 Global Meningococcal Vaccine Breakdown Data by Company
3.1.1 Global Meningococcal Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Meningococcal Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Meningococcal Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Meningococcal Vaccine Revenue by Company (2019-2024)
3.2.2 Global Meningococcal Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Meningococcal Vaccine Sale Price by Company
3.4 Key Manufacturers Meningococcal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meningococcal Vaccine Product Location Distribution
3.4.2 Players Meningococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MENINGOCOCCAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Meningococcal Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Meningococcal Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Meningococcal Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Meningococcal Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Meningococcal Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Meningococcal Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Meningococcal Vaccine Sales Growth
4.4 APAC Meningococcal Vaccine Sales Growth
4.5 Europe Meningococcal Vaccine Sales Growth
4.6 Middle East & Africa Meningococcal Vaccine Sales Growth
5 AMERICAS
5.1 Americas Meningococcal Vaccine Sales by Country
5.1.1 Americas Meningococcal Vaccine Sales by Country (2019-2024)
5.1.2 Americas Meningococcal Vaccine Revenue by Country (2019-2024)
5.2 Americas Meningococcal Vaccine Sales by Type
5.3 Americas Meningococcal Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meningococcal Vaccine Sales by Region
6.1.1 APAC Meningococcal Vaccine Sales by Region (2019-2024)
6.1.2 APAC Meningococcal Vaccine Revenue by Region (2019-2024)
6.2 APAC Meningococcal Vaccine Sales by Type
6.3 APAC Meningococcal Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Meningococcal Vaccine by Country
7.1.1 Europe Meningococcal Vaccine Sales by Country (2019-2024)
7.1.2 Europe Meningococcal Vaccine Revenue by Country (2019-2024)
7.2 Europe Meningococcal Vaccine Sales by Type
7.3 Europe Meningococcal Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Meningococcal Vaccine by Country
8.1.1 Middle East & Africa Meningococcal Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Meningococcal Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Meningococcal Vaccine Sales by Type
8.3 Middle East & Africa Meningococcal Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meningococcal Vaccine
10.3 Manufacturing Process Analysis of Meningococcal Vaccine
10.4 Industry Chain Structure of Meningococcal Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meningococcal Vaccine Distributors
11.3 Meningococcal Vaccine Customer
12 WORLD FORECAST REVIEW FOR MENINGOCOCCAL VACCINE BY GEOGRAPHIC REGION
12.1 Global Meningococcal Vaccine Market Size Forecast by Region
12.1.1 Global Meningococcal Vaccine Forecast by Region (2025-2030)
12.1.2 Global Meningococcal Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Meningococcal Vaccine Forecast by Type
12.7 Global Meningococcal Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Meningococcal Vaccine Product Portfolios and Specifications
13.1.3 Novartis Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Meningococcal Vaccine Product Portfolios and Specifications
13.2.3 GSK Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Meningococcal Vaccine Product Portfolios and Specifications
13.3.3 Merck Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 CSL
13.4.1 CSL Company Information
13.4.2 CSL Meningococcal Vaccine Product Portfolios and Specifications
13.4.3 CSL Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CSL Main Business Overview
13.4.5 CSL Latest Developments
13.5 Baxter
13.5.1 Baxter Company Information
13.5.2 Baxter Meningococcal Vaccine Product Portfolios and Specifications
13.5.3 Baxter Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Baxter Main Business Overview
13.5.5 Baxter Latest Developments
13.6 JN International Medical Corporation
13.6.1 JN International Medical Corporation Company Information
13.6.2 JN International Medical Corporation Meningococcal Vaccine Product Portfolios and Specifications
13.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 JN International Medical Corporation Main Business Overview
13.6.5 JN International Medical Corporation Latest Developments
13.7 Serum Institute of India
13.7.1 Serum Institute of India Company Information
13.7.2 Serum Institute of India Meningococcal Vaccine Product Portfolios and Specifications
13.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Serum Institute of India Main Business Overview
13.7.5 Serum Institute of India Latest Developments
13.8 Bio-Med
13.8.1 Bio-Med Company Information
13.8.2 Bio-Med Meningococcal Vaccine Product Portfolios and Specifications
13.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Bio-Med Main Business Overview
13.8.5 Bio-Med Latest Developments
13.9 China National Biotec Group
13.9.1 China National Biotec Group Company Information
13.9.2 China National Biotec Group Meningococcal Vaccine Product Portfolios and Specifications
13.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 China National Biotec Group Main Business Overview
13.9.5 China National Biotec Group Latest Developments
13.10 Hualan Bio
13.10.1 Hualan Bio Company Information
13.10.2 Hualan Bio Meningococcal Vaccine Product Portfolios and Specifications
13.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Hualan Bio Main Business Overview
13.10.5 Hualan Bio Latest Developments
13.11 Walvax
13.11.1 Walvax Company Information
13.11.2 Walvax Meningococcal Vaccine Product Portfolios and Specifications
13.11.3 Walvax Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Walvax Main Business Overview
13.11.5 Walvax Latest Developments
13.12 Zhifei
13.12.1 Zhifei Company Information
13.12.2 Zhifei Meningococcal Vaccine Product Portfolios and Specifications
13.12.3 Zhifei Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Zhifei Main Business Overview
13.12.5 Zhifei Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Meningococcal Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Meningococcal Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Meningtits A
Table 4. Major Players of Polysaccharide Meningtitis AC
Table 5. Major Players of Meningitis ACYW
Table 6. Global Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)
Table 7. Global Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Table 8. Global Meningococcal Vaccine Revenue by Type (2019-2024) & ($ million)
Table 9. Global Meningococcal Vaccine Revenue Market Share by Type (2019-2024)
Table 10. Global Meningococcal Vaccine Sale Price by Type (2019-2024) & (USD/Pcs)
Table 11. Global Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)
Table 12. Global Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Table 13. Global Meningococcal Vaccine Revenue by Application (2019-2024)
Table 14. Global Meningococcal Vaccine Revenue Market Share by Application (2019-2024)
Table 15. Global Meningococcal Vaccine Sale Price by Application (2019-2024) & (USD/Pcs)
Table 16. Global Meningococcal Vaccine Sales by Company (2019-2024) & (10K Pcs)
Table 17. Global Meningococcal Vaccine Sales Market Share by Company (2019-2024)
Table 18. Global Meningococcal Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Meningococcal Vaccine Revenue Market Share by Company (2019-2024)
Table 20. Global Meningococcal Vaccine Sale Price by Company (2019-2024) & (USD/Pcs)
Table 21. Key Manufacturers Meningococcal Vaccine Producing Area Distribution and Sales Area
Table 22. Players Meningococcal Vaccine Products Offered
Table 23. Meningococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Meningococcal Vaccine Sales by Geographic Region (2019-2024) & (10K Pcs)
Table 27. Global Meningococcal Vaccine Sales Market Share Geographic Region (2019-2024)
Table 28. Global Meningococcal Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Meningococcal Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Meningococcal Vaccine Sales by Country/Region (2019-2024) & (10K Pcs)
Table 31. Global Meningococcal Vaccine Sales Market Share by Country/Region (2019-2024)
Table 32. Global Meningococcal Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Meningococcal Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
Table 35. Americas Meningococcal Vaccine Sales Market Share by Country (2019-2024)
Table 36. Americas Meningococcal Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Meningococcal Vaccine Revenue Market Share by Country (2019-2024)
Table 38. Americas Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)
Table 39. Americas Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)
Table 40. APAC Meningococcal Vaccine Sales by Region (2019-2024) & (10K Pcs)
Table 41. APAC Meningococcal Vaccine Sales Market Share by Region (2019-2024)
Table 42. APAC Meningococcal Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Meningococcal Vaccine Revenue Market Share by Region (2019-2024)
Table 44. APAC Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)
Table 45. APAC Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)
Table 46. Europe Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
Table 47. Europe Meningococcal Vaccine Sales Market Share by Country (2019-2024)
Table 48. Europe Meningococcal Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Meningococcal Vaccine Revenue Market Share by Country (2019-2024)
Table 50. Europe Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)
Table 51. Europe Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)
Table 52. Middle East & Africa Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
Table 53. Middle East & Africa Meningococcal Vaccine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Meningococcal Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)
Table 57. Middle East & Africa Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)
Table 58. Key Market Drivers & Growth Opportunities of Meningococcal Vaccine
Table 59. Key Market Challenges & Risks of Meningococcal Vaccine
Table 60. Key Industry Trends of Meningococcal Vaccine
Table 61. Meningococcal Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Meningococcal Vaccine Distributors List
Table 64. Meningococcal Vaccine Customer List
Table 65. Global Meningococcal Vaccine Sales Forecast by Region (2025-2030) & (10K Pcs)
Table 66. Global Meningococcal Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (10K Pcs)
Table 68. Americas Meningococcal Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Meningococcal Vaccine Sales Forecast by Region (2025-2030) & (10K Pcs)
Table 70. APAC Meningococcal Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (10K Pcs)
Table 72. Europe Meningococcal Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (10K Pcs)
Table 74. Middle East & Africa Meningococcal Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Meningococcal Vaccine Sales Forecast by Type (2025-2030) & (10K Pcs)
Table 76. Global Meningococcal Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Meningococcal Vaccine Sales Forecast by Application (2025-2030) & (10K Pcs)
Table 78. Global Meningococcal Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Novartis Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Meningococcal Vaccine Product Portfolios and Specifications
Table 81. Novartis Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. GSK Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. GSK Meningococcal Vaccine Product Portfolios and Specifications
Table 86. GSK Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 87. GSK Main Business
Table 88. GSK Latest Developments
Table 89. Merck Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Merck Meningococcal Vaccine Product Portfolios and Specifications
Table 91. Merck Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 92. Merck Main Business
Table 93. Merck Latest Developments
Table 94. CSL Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. CSL Meningococcal Vaccine Product Portfolios and Specifications
Table 96. CSL Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 97. CSL Main Business
Table 98. CSL Latest Developments
Table 99. Baxter Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Baxter Meningococcal Vaccine Product Portfolios and Specifications
Table 101. Baxter Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 102. Baxter Main Business
Table 103. Baxter Latest Developments
Table 104. JN International Medical Corporation Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. JN International Medical Corporation Meningococcal Vaccine Product Portfolios and Specifications
Table 106. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 107. JN International Medical Corporation Main Business
Table 108. JN International Medical Corporation Latest Developments
Table 109. Serum Institute of India Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Serum Institute of India Meningococcal Vaccine Product Portfolios and Specifications
Table 111. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 112. Serum Institute of India Main Business
Table 113. Serum Institute of India Latest Developments
Table 114. Bio-Med Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Bio-Med Meningococcal Vaccine Product Portfolios and Specifications
Table 116. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 117. Bio-Med Main Business
Table 118. Bio-Med Latest Developments
Table 119. China National Biotec Group Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. China National Biotec Group Meningococcal Vaccine Product Portfolios and Specifications
Table 121. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 122. China National Biotec Group Main Business
Table 123. China National Biotec Group Latest Developments
Table 124. Hualan Bio Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. Hualan Bio Meningococcal Vaccine Product Portfolios and Specifications
Table 126. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 127. Hualan Bio Main Business
Table 128. Hualan Bio Latest Developments
Table 129. Walvax Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Walvax Meningococcal Vaccine Product Portfolios and Specifications
Table 131. Walvax Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 132. Walvax Main Business
Table 133. Walvax Latest Developments
Table 134. Zhifei Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. Zhifei Meningococcal Vaccine Product Portfolios and Specifications
Table 136. Zhifei Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 137. Zhifei Main Business
Table 138. Zhifei Latest Developments
Table 1. Meningococcal Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Meningococcal Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Meningtits A
Table 4. Major Players of Polysaccharide Meningtitis AC
Table 5. Major Players of Meningitis ACYW
Table 6. Global Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)
Table 7. Global Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Table 8. Global Meningococcal Vaccine Revenue by Type (2019-2024) & ($ million)
Table 9. Global Meningococcal Vaccine Revenue Market Share by Type (2019-2024)
Table 10. Global Meningococcal Vaccine Sale Price by Type (2019-2024) & (USD/Pcs)
Table 11. Global Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)
Table 12. Global Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Table 13. Global Meningococcal Vaccine Revenue by Application (2019-2024)
Table 14. Global Meningococcal Vaccine Revenue Market Share by Application (2019-2024)
Table 15. Global Meningococcal Vaccine Sale Price by Application (2019-2024) & (USD/Pcs)
Table 16. Global Meningococcal Vaccine Sales by Company (2019-2024) & (10K Pcs)
Table 17. Global Meningococcal Vaccine Sales Market Share by Company (2019-2024)
Table 18. Global Meningococcal Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Meningococcal Vaccine Revenue Market Share by Company (2019-2024)
Table 20. Global Meningococcal Vaccine Sale Price by Company (2019-2024) & (USD/Pcs)
Table 21. Key Manufacturers Meningococcal Vaccine Producing Area Distribution and Sales Area
Table 22. Players Meningococcal Vaccine Products Offered
Table 23. Meningococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Meningococcal Vaccine Sales by Geographic Region (2019-2024) & (10K Pcs)
Table 27. Global Meningococcal Vaccine Sales Market Share Geographic Region (2019-2024)
Table 28. Global Meningococcal Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Meningococcal Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Meningococcal Vaccine Sales by Country/Region (2019-2024) & (10K Pcs)
Table 31. Global Meningococcal Vaccine Sales Market Share by Country/Region (2019-2024)
Table 32. Global Meningococcal Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Meningococcal Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
Table 35. Americas Meningococcal Vaccine Sales Market Share by Country (2019-2024)
Table 36. Americas Meningococcal Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Meningococcal Vaccine Revenue Market Share by Country (2019-2024)
Table 38. Americas Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)
Table 39. Americas Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)
Table 40. APAC Meningococcal Vaccine Sales by Region (2019-2024) & (10K Pcs)
Table 41. APAC Meningococcal Vaccine Sales Market Share by Region (2019-2024)
Table 42. APAC Meningococcal Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Meningococcal Vaccine Revenue Market Share by Region (2019-2024)
Table 44. APAC Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)
Table 45. APAC Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)
Table 46. Europe Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
Table 47. Europe Meningococcal Vaccine Sales Market Share by Country (2019-2024)
Table 48. Europe Meningococcal Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Meningococcal Vaccine Revenue Market Share by Country (2019-2024)
Table 50. Europe Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)
Table 51. Europe Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)
Table 52. Middle East & Africa Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
Table 53. Middle East & Africa Meningococcal Vaccine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Meningococcal Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)
Table 57. Middle East & Africa Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)
Table 58. Key Market Drivers & Growth Opportunities of Meningococcal Vaccine
Table 59. Key Market Challenges & Risks of Meningococcal Vaccine
Table 60. Key Industry Trends of Meningococcal Vaccine
Table 61. Meningococcal Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Meningococcal Vaccine Distributors List
Table 64. Meningococcal Vaccine Customer List
Table 65. Global Meningococcal Vaccine Sales Forecast by Region (2025-2030) & (10K Pcs)
Table 66. Global Meningococcal Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (10K Pcs)
Table 68. Americas Meningococcal Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Meningococcal Vaccine Sales Forecast by Region (2025-2030) & (10K Pcs)
Table 70. APAC Meningococcal Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (10K Pcs)
Table 72. Europe Meningococcal Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (10K Pcs)
Table 74. Middle East & Africa Meningococcal Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Meningococcal Vaccine Sales Forecast by Type (2025-2030) & (10K Pcs)
Table 76. Global Meningococcal Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Meningococcal Vaccine Sales Forecast by Application (2025-2030) & (10K Pcs)
Table 78. Global Meningococcal Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Novartis Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Meningococcal Vaccine Product Portfolios and Specifications
Table 81. Novartis Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. GSK Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. GSK Meningococcal Vaccine Product Portfolios and Specifications
Table 86. GSK Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 87. GSK Main Business
Table 88. GSK Latest Developments
Table 89. Merck Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Merck Meningococcal Vaccine Product Portfolios and Specifications
Table 91. Merck Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 92. Merck Main Business
Table 93. Merck Latest Developments
Table 94. CSL Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. CSL Meningococcal Vaccine Product Portfolios and Specifications
Table 96. CSL Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 97. CSL Main Business
Table 98. CSL Latest Developments
Table 99. Baxter Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Baxter Meningococcal Vaccine Product Portfolios and Specifications
Table 101. Baxter Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 102. Baxter Main Business
Table 103. Baxter Latest Developments
Table 104. JN International Medical Corporation Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. JN International Medical Corporation Meningococcal Vaccine Product Portfolios and Specifications
Table 106. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 107. JN International Medical Corporation Main Business
Table 108. JN International Medical Corporation Latest Developments
Table 109. Serum Institute of India Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Serum Institute of India Meningococcal Vaccine Product Portfolios and Specifications
Table 111. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 112. Serum Institute of India Main Business
Table 113. Serum Institute of India Latest Developments
Table 114. Bio-Med Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Bio-Med Meningococcal Vaccine Product Portfolios and Specifications
Table 116. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 117. Bio-Med Main Business
Table 118. Bio-Med Latest Developments
Table 119. China National Biotec Group Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. China National Biotec Group Meningococcal Vaccine Product Portfolios and Specifications
Table 121. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 122. China National Biotec Group Main Business
Table 123. China National Biotec Group Latest Developments
Table 124. Hualan Bio Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. Hualan Bio Meningococcal Vaccine Product Portfolios and Specifications
Table 126. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 127. Hualan Bio Main Business
Table 128. Hualan Bio Latest Developments
Table 129. Walvax Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Walvax Meningococcal Vaccine Product Portfolios and Specifications
Table 131. Walvax Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 132. Walvax Main Business
Table 133. Walvax Latest Developments
Table 134. Zhifei Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. Zhifei Meningococcal Vaccine Product Portfolios and Specifications
Table 136. Zhifei Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 137. Zhifei Main Business
Table 138. Zhifei Latest Developments
LIST OF FIGURES
Figure 1. Picture of Meningococcal Vaccine
Figure 2. Meningococcal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meningococcal Vaccine Sales Growth Rate 2019-2030 (10K Pcs)
Figure 7. Global Meningococcal Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Meningococcal Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Meningtits A
Figure 10. Product Picture of Polysaccharide Meningtitis AC
Figure 11. Product Picture of Meningitis ACYW
Figure 12. Global Meningococcal Vaccine Sales Market Share by Type in 2023
Figure 13. Global Meningococcal Vaccine Revenue Market Share by Type (2019-2024)
Figure 14. Meningococcal Vaccine Consumed in 6 Months-15Year
Figure 15. Global Meningococcal Vaccine Market: 6 Months-15Year (2019-2024) & (10K Pcs)
Figure 16. Meningococcal Vaccine Consumed in over 3 Year
Figure 17. Global Meningococcal Vaccine Market: over 3 Year (2019-2024) & (10K Pcs)
Figure 18. Meningococcal Vaccine Consumed in over 2 Year
Figure 19. Global Meningococcal Vaccine Market: over 2 Year (2019-2024) & (10K Pcs)
Figure 20. Meningococcal Vaccine Consumed in over 3 Months
Figure 21. Global Meningococcal Vaccine Market: over 3 Months (2019-2024) & (10K Pcs)
Figure 22. Global Meningococcal Vaccine Sales Market Share by Application (2023)
Figure 23. Global Meningococcal Vaccine Revenue Market Share by Application in 2023
Figure 24. Meningococcal Vaccine Sales Market by Company in 2023 (10K Pcs)
Figure 25. Global Meningococcal Vaccine Sales Market Share by Company in 2023
Figure 26. Meningococcal Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 27. Global Meningococcal Vaccine Revenue Market Share by Company in 2023
Figure 28. Global Meningococcal Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Meningococcal Vaccine Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Meningococcal Vaccine Sales 2019-2024 (10K Pcs)
Figure 31. Americas Meningococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 32. APAC Meningococcal Vaccine Sales 2019-2024 (10K Pcs)
Figure 33. APAC Meningococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 34. Europe Meningococcal Vaccine Sales 2019-2024 (10K Pcs)
Figure 35. Europe Meningococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Meningococcal Vaccine Sales 2019-2024 (10K Pcs)
Figure 37. Middle East & Africa Meningococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 38. Americas Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 39. Americas Meningococcal Vaccine Revenue Market Share by Country in 2023
Figure 40. Americas Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 41. Americas Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Figure 42. United States Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC Meningococcal Vaccine Sales Market Share by Region in 2023
Figure 47. APAC Meningococcal Vaccine Revenue Market Share by Regions in 2023
Figure 48. APAC Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 49. APAC Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Figure 50. China Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. India Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 58. Europe Meningococcal Vaccine Revenue Market Share by Country in 2023
Figure 59. Europe Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 60. Europe Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Figure 61. Germany Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. France Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 67. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Figure 70. Egypt Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Meningococcal Vaccine in 2023
Figure 76. Manufacturing Process Analysis of Meningococcal Vaccine
Figure 77. Industry Chain Structure of Meningococcal Vaccine
Figure 78. Channels of Distribution
Figure 79. Global Meningococcal Vaccine Sales Market Forecast by Region (2025-2030)
Figure 80. Global Meningococcal Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Meningococcal Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Meningococcal Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Meningococcal Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Meningococcal Vaccine
Figure 2. Meningococcal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meningococcal Vaccine Sales Growth Rate 2019-2030 (10K Pcs)
Figure 7. Global Meningococcal Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Meningococcal Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Meningtits A
Figure 10. Product Picture of Polysaccharide Meningtitis AC
Figure 11. Product Picture of Meningitis ACYW
Figure 12. Global Meningococcal Vaccine Sales Market Share by Type in 2023
Figure 13. Global Meningococcal Vaccine Revenue Market Share by Type (2019-2024)
Figure 14. Meningococcal Vaccine Consumed in 6 Months-15Year
Figure 15. Global Meningococcal Vaccine Market: 6 Months-15Year (2019-2024) & (10K Pcs)
Figure 16. Meningococcal Vaccine Consumed in over 3 Year
Figure 17. Global Meningococcal Vaccine Market: over 3 Year (2019-2024) & (10K Pcs)
Figure 18. Meningococcal Vaccine Consumed in over 2 Year
Figure 19. Global Meningococcal Vaccine Market: over 2 Year (2019-2024) & (10K Pcs)
Figure 20. Meningococcal Vaccine Consumed in over 3 Months
Figure 21. Global Meningococcal Vaccine Market: over 3 Months (2019-2024) & (10K Pcs)
Figure 22. Global Meningococcal Vaccine Sales Market Share by Application (2023)
Figure 23. Global Meningococcal Vaccine Revenue Market Share by Application in 2023
Figure 24. Meningococcal Vaccine Sales Market by Company in 2023 (10K Pcs)
Figure 25. Global Meningococcal Vaccine Sales Market Share by Company in 2023
Figure 26. Meningococcal Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 27. Global Meningococcal Vaccine Revenue Market Share by Company in 2023
Figure 28. Global Meningococcal Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Meningococcal Vaccine Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Meningococcal Vaccine Sales 2019-2024 (10K Pcs)
Figure 31. Americas Meningococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 32. APAC Meningococcal Vaccine Sales 2019-2024 (10K Pcs)
Figure 33. APAC Meningococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 34. Europe Meningococcal Vaccine Sales 2019-2024 (10K Pcs)
Figure 35. Europe Meningococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Meningococcal Vaccine Sales 2019-2024 (10K Pcs)
Figure 37. Middle East & Africa Meningococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 38. Americas Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 39. Americas Meningococcal Vaccine Revenue Market Share by Country in 2023
Figure 40. Americas Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 41. Americas Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Figure 42. United States Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC Meningococcal Vaccine Sales Market Share by Region in 2023
Figure 47. APAC Meningococcal Vaccine Revenue Market Share by Regions in 2023
Figure 48. APAC Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 49. APAC Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Figure 50. China Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. India Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 58. Europe Meningococcal Vaccine Revenue Market Share by Country in 2023
Figure 59. Europe Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 60. Europe Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Figure 61. Germany Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. France Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 67. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Figure 70. Egypt Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country Meningococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Meningococcal Vaccine in 2023
Figure 76. Manufacturing Process Analysis of Meningococcal Vaccine
Figure 77. Industry Chain Structure of Meningococcal Vaccine
Figure 78. Channels of Distribution
Figure 79. Global Meningococcal Vaccine Sales Market Forecast by Region (2025-2030)
Figure 80. Global Meningococcal Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Meningococcal Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Meningococcal Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Meningococcal Vaccine Revenue Market Share Forecast by Application (2025-2030)
